Company / Operating Cash Flow
PLUS THERAPEUTICS, INC. Operating Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$10.6M
FY2025
5-year range
-$20.5M / -$10.6M
FY2021-FY2025
Trend
+17.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 5 consecutive years, from -$35M in FY2015 to -$11M in FY2025.
Based on SEC 10-K filings.
-$11M in FY2025.
Improved from -$18M to -$11M over the past 7 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PLUS THERAPEUTICS, INC.'s operating cash flow has grown for 5 consecutive years.
- In FY2025, operating cash flow increased 17.9% year-over-year.
- Lowest operating cash flow in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.6M | +17.9% |
| FY2024 | -$12.9M | +29.1% |
| FY2018 | -$18.1M | +7.2% |
| FY2017 | -$19.5M | +4.6% |
| FY2016 | -$20.5M | +40.8% |
| FY2015 | -$34.6M | -7.4% |
| FY2014 | -$32.2M | +8.9% |
| FY2013 | -$35.3M | -49.8% |
| FY2012 | -$23.6M | +1.0% |
| FY2011 | -$23.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026